Plain-English translation of NCT06662084 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how temporary mechanical heart support devices—like ECMO or Impella pumps—affect the way your body processes medications. When your heart is in severe shock and needs machine support, the stress on your body might change how medications work. This study will use blood tests to measure these changes and understand whether patients on these devices need different medication doses or timing.
When patients are on temporary heart support devices, their body is under extreme stress and working differently than normal. This may change how medications are broken down and absorbed, which could affect how well treatments work. Understanding these changes will help doctors give safer, more effective medications to patients on these devices.
You likely qualify if…
You likely don't qualify if…
You will have blood samples taken twice: once within 3 days after your heart support device is placed, and again 14 days after the device is removed (once your heart is stable enough). During the first blood draw, you'll also receive a special medication mixture (the Geneva cocktail) by mouth or feeding tube to help measure how your body is processing medications. The study compares your results with a control group of heart failure patients not on mechanical support.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
Switzerland
Sponsor
University Hospital, Geneva
Collaborators
Jean Terrier, Benjamin Assouline
Enrollment target
~46 participants
Started
October 2024
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jean Terrier, Dr
University Hospital, Geneva
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.